Independent verification notes on cosmetic medicine in South Korea

Seoul · No sponsorship, no clinic names, no paid placements

Author: The Clinic Notes

  • Sending a Patient to a Korean Clinic for Money Is a Crime. Foreign Patients Are the Only Exception.

    Note №36WHO IS ALLOWED TO REFER YOU

    VERIFIED2026-09-03
    PRIMARY SOURCES7
    CLINICS NAMED0
    SPONSORSHIPNONE

    If a coordinator, agency, or acquaintance arranged your procedure in Seoul and was paid for arranging it, that arrangement sits on top of a criminal prohibition. Korea’s Medical Service Act bans referring, brokering, or luring a patient to a medical institution for profit. The penalty is up to three years in prison or a fine of up to 30 million won. There is no professional exemption: the text begins with anyone.

    Foreign patients are the carve-out. Not one of several — the single one that matters here. The statute suspends the referral ban for the specific purpose of attracting patients from abroad, and then a separate Act attaches conditions to that suspension: both the clinic and the facilitator have to be on a government register, and a registered clinic owes the patient a short list of things in writing.

    Most foreign patients never learn any of this, because the register is in Korean and the paperwork obligations are written as duties owed to them rather than as rights they can name. This note sets out what the statutes actually say, what the registration means, and where the register can be checked.

    The default rule: brokering patients is criminal

    Article 27(3) of the Medical Service Act (의료법 제27조제3항) reads, in the operative part: no person shall, for profit, introduce, broker, or lure a patient to a medical institution or a medical practitioner, nor abet such an act. Two features of that sentence do the work.

    First, the subject is “no person” (누구든지). It is not limited to licensed intermediaries or to registered businesses. A hospital marketing employee, a hotel concierge, an influencer taking a per-head fee, and a friend collecting a commission are all inside the sentence.

    Second, the ban reaches the clinic as well as the broker. The phrase “nor abet such an act” (이를 사주하는 행위) puts the party who instigates the referral inside the same prohibition. A clinic that commissions a broker is not a bystander to the broker’s offence.

    Article 88, subparagraph 1 (의료법 제88조 제1호) sets the sentence for a violation of Article 27(3) or (4) at imprisonment for up to three years or a fine of up to 30 million won. Article 27(4) separately bars insurance companies and their agents and solicitors from foreign-patient facilitation.

    The exception exists, and it is defined by who you are not

    The proviso to Article 27(3) lists exceptions, and subparagraph 2 is the foreign-patient one. It permits acts undertaken to attract a patient who is a foreigner and who is not a subscriber or dependent under Article 109 of the National Health Insurance Act.

    That second condition is the part people miss. The carve-out is not written around nationality alone. It is written around enrolment in Korea’s national health insurance. A foreign national who lives in Korea, works here, and is enrolled in NHI is not inside the exception — for that person the ordinary criminal prohibition on paid referral still applies, exactly as it would for a Korean patient. The exception is for people whose care Korea is not paying for.

    This is a coherent design rather than an accident. Paid referral is banned in Korea because it distorts a system in which most treatment is publicly reimbursed. Where no public money is at stake, the policy reason for the ban falls away, and the state instead wants the activity visible and regulated. Hence a register.

    The exception is not automatic. It runs through a register.

    The Act on Support for Overseas Expansion of Healthcare System and Attraction of Foreign Patients (의료 해외진출 및 외국인환자 유치 지원에 관한 법률, in force since 2016) governs the register. Article 6 requires anyone who wants to attract foreign patients — a medical institution or a facilitating agency — to register with the Minister of Health and Welfare, and sets different conditions for the two categories.

    A medical institution must hold medical accident liability insurance or an equivalent arrangement, and must employ specialists in the departments for which it intends to attract patients. An agency must hold guarantee insurance, meet a capital requirement, and maintain an office inside Korea. The statute states the categories of requirement; the numeric thresholds sit in the Enforcement Decree, which this note did not read and therefore does not quote.

    The government service listing for the medical-institution registration gives a standard processing period of about 20 days, with the application filed to the Ministry of Health and Welfare through the online system (gov.kr, accessed 2026-09-03).

    What a registered clinic owes you in writing

    Article 8 of the same Act is headed “Protection of the rights and interests of foreign patients” (외국인환자의 권익 보호), and it is the provision most worth knowing, because it converts registration from a licence into a set of documents.

    Article 8(1) requires the registration certificate to be displayed in a place where anyone can see it. Not filed, not produced on request — displayed. If you are standing in a clinic that says it treats foreign patients and there is no registration certificate on the wall, that is a fact you can observe without asking a question.

    Article 8(2) requires a registered medical institution to post the rights of foreign patients in a foreign language, keep printed copies available on the premises, and separately provide the patient with three specific things:

    Item What the statute names
    1 The diagnosis, the method of treatment, and the side effects that may occur
    2 A treatment contract and an estimate of expected medical charges, on a form prescribed by the Minister of Health and Welfare
    3 The dispute resolution procedure applicable if a medical accident occurs

    Item 2 is the unusual one. A written cost estimate on a ministry-prescribed form is not a courtesy that a good clinic extends; for a registered institution treating a foreign patient it is a statutory deliverable. That is a different thing from the price list a clinic shows you on a tablet during a consultation, and it is worth asking for by name. What the expected charge will actually contain is a separate question — cosmetic procedures lose the VAT exemption that ordinary medical care enjoys, which changes the number by ten per cent.

    Article 31(1), subparagraph 1 makes a violation of Article 8(1) — the display duty — punishable by an administrative fine of up to 5 million won. This note confirmed the sanction attached to Article 8(1). It did not confirm which sanction, if any, attaches specifically to a failure under Article 8(2), and does not assert one.

    Both sides have to be registered, not just one

    Article 24(1) lists the grounds on which a registration can be cancelled, and two of them are structural rather than disciplinary.

    Subparagraph 3 reaches a registered agency that refers a foreign patient to a medical institution which is not registered. Subparagraph 4 reaches a registered medical institution that accepts a foreign patient referred by a party which is not registered.

    The consequence is that registration only works in matched pairs. An agency’s registration certificate tells you nothing about the clinic it is sending you to, and a clinic’s certificate tells you nothing about the agency that found you. Each has to be checked separately, and a mismatch is not a technicality — it is a cancellation ground for whichever side is registered.

    Where the register can be checked

    Two routes exist, both operated by or through the Korea Health Industry Development Institute (한국보건산업진흥원) under the Ministry of Health and Welfare.

    The first is the foreign-patient facilitation information system at medicalkorea.or.kr, whose front page carries lookups for registered institutions by business registration number, and for facilitating institutions by name or region. The interface is Korean-only. This note did not test whether every lookup completes without a login.

    The second is a downloadable dataset. The Institute publishes the status of foreign-patient facilitating institutions as open data on Korea’s public data portal, data.go.kr, as a free CSV and through an open API. The edition listed on the portal when this note was written contains 6,921 institutions, with fields for institution number and status, name, representative, facility type, and location, and is scheduled for annual update (accessed 2026-09-03). It is a spreadsheet rather than a search box, which for a reader outside Korea is arguably easier: a name search in a downloaded file does not require reading the site.

    For scale: 6,921 registered facilitating institutions is the supply side of a market that recorded 2.01 million foreign patients in 2025, of whom 62.9 per cent went to dermatology.

    What this note does not establish

    It does not establish how often Article 27(3) is enforced against unregistered facilitation of foreign patients, or whether prosecutions occur at all. Enforcement statistics were not located.

    It does not establish the numeric thresholds in Article 6 — the capital figure for agencies, the insurance coverage amounts, or the specialist headcount formula. Those are in the Enforcement Decree and Enforcement Rules, which were not read for this note.

    It does not establish what the ministry-prescribed treatment contract form looks like, whether an official English version exists, or whether clinics in practice hand it over. The statute creates the duty; this note did not observe compliance.

    It does not establish that an unregistered clinic is unsafe or unlicensed. Registration under this Act is separate from a medical institution’s licence to operate. An unregistered clinic may be a perfectly ordinary Korean clinic that simply does not participate in the foreign-patient scheme — but if it accepts patients referred by a facilitator, the referral sits outside the carve-out.

    It does not give legal advice, and nothing here should be read as an opinion on any particular arrangement.

    Common questions

    Am I committing an offence by using an agency?

    The prohibition in Article 27(3) is directed at the person who refers, brokers, or lures for profit, and at the person who abets that act. The patient being referred is not named as an offender. The exposure sits with the facilitator and with the clinic that commissions one.

    Does the foreign-patient exception apply to me if I live in Korea?

    The proviso is written for a foreigner who is not a subscriber or dependent under Article 109 of the National Health Insurance Act. If you are enrolled in Korean NHI, you fall outside the wording of the exception, and the ordinary prohibition applies to anyone who refers you for profit.

    What should be on the wall of a registered clinic?

    Article 8(1) requires the registration certificate to be displayed where anyone can see it. Article 8(2) additionally requires the rights of foreign patients to be posted in a foreign language, with printed copies kept on the premises.

    Can I ask for a written cost estimate before treatment?

    Article 8(2), item 2 requires a registered medical institution to provide a foreign patient with a treatment contract and an estimate of expected medical charges on a form prescribed by the Minister of Health and Welfare. This note did not verify what that form contains or how consistently it is used.

    My agency is registered. Is that enough?

    No. Article 24(1), subparagraph 3 makes it a cancellation ground for a registered agency to refer a patient to an unregistered medical institution, and subparagraph 4 makes it a cancellation ground for a registered institution to accept a patient from an unregistered referrer. The two registrations are checked separately.

    How do I look up a clinic if I cannot read Korean?

    The open dataset on data.go.kr downloads as a CSV containing 6,921 institutions in the edition current when this note was written, including institution name, representative, facility type, and location. A text search in that file does not require navigating a Korean-language site. The lookup interface at medicalkorea.or.kr is Korean-only.

    Related notes

    Other rights in Korean clinics that exist as a form rather than as a favour: the operating-room camera must be installed, but recording it requires a written request, and your treatment records remain claimable after you have flown home.

    Sources

    • 의료법 (Medical Service Act) Article 27(3), (4) — National Law Information Center, law.go.kr, accessed 2026-09-03
    • 의료법 Article 88, subparagraph 1 — law.go.kr, accessed 2026-09-03
    • 의료 해외진출 및 외국인환자 유치 지원에 관한 법률 Article 6 (registration) — law.go.kr, accessed 2026-09-03
    • Same Act, Article 8 (protection of the rights and interests of foreign patients) — law.go.kr, accessed 2026-09-03
    • Same Act, Article 24(1), subparagraphs 3 and 4 (grounds for cancellation of registration) — law.go.kr, accessed 2026-09-03
    • Same Act, Article 31(1), subparagraph 1 (administrative fine) — law.go.kr, accessed 2026-09-03
    • “외국인환자 유치 의료기관 등록 신청” service listing — gov.kr, accessed 2026-09-03
    • 한국보건산업진흥원 「외국인환자 유치기관 현황」 open dataset — data.go.kr, accessed 2026-09-03
    • 외국인환자유치정보시스템 — medicalkorea.or.kr, accessed 2026-09-03

    The Clinic Notes — verified, source-cited information on cosmetic medicine in South Korea. We accept no payments or benefits from clinics, hospitals, doctors, or referral agencies.

  • Ask to See the Box. Korean Law Lists Eight Things That Must Be Printed on It.

    Note №35WHAT TO CHECK

    VERIFIED2026-08-24
    PRIMARY SOURCES5
    CLINICS NAMED0
    SPONSORSHIPNONE

    Some patients ask the clinic to open the product box in front of them. We cannot tell you how common that is and we are not going to pretend otherwise — but we can tell you whether it accomplishes anything. Korean law prints a fixed list of items on that box, and two of them can be checked against a public government database before the needle comes out. We read the statutes in the original on 24 August 2026.

    The request is simple enough: don’t bring it pre-loaded, open it here. It is easy to dismiss as theatre. It is not quite theatre — but what it proves is narrower than people think, and the useful part happens after the box is open, not when it is.

    Filler and toxin are not the same kind of thing

    This is where most patients go wrong before they even look at the packaging. In Korea, a dermal filler and a botulinum toxin sit under two different Acts, with two different labelling regimes and two different public databases.

    A filler is a medical device. It falls under the Medical Devices Act, and what must be printed on its container or outer packaging is set out in Article 20.

    A toxin is a prescription drug. It falls under the Pharmaceutical Affairs Act, and its labelling requirements are in Article 56.

    So “is it genuine?” is really two questions with two different answers, and the thing you are supposed to read differs between them. We have written before about how the same device carries different names in different markets — this is the same problem one layer down, at the level of the box in the room.

    What the law requires on a device box

    Article 20 of the Medical Devices Act requires the manufacturer or importer to print the following on the container or outer packaging:

    • the trade name and address of the manufacturer or importer;
    • for an imported product, the country of manufacture and the manufacturer’s name;
    • the licence, certification or notification number, and the name of the item — product name, item name, model name;
    • the manufacturing number and the year and month of manufacture — or the use-by date in its place;
    • the weight or packaging unit;
    • the words “medical device”;
    • where the product is single-use: the words “single use” and “do not reuse”;
    • the medical device standard code set by the Minister of Food and Drug Safety in consultation with the Minister of Health and Welfare.

    Two of those are checkable by a patient standing in the room: the licence number and the standard code. The rest are context.

    What the law requires on a drug vial

    Article 56(1) of the Pharmaceutical Affairs Act requires the licence holder or importer to print on the container or packaging, among other things:

    • the trade name and address of the licence holder or importer — including the manufacturing site where production was contracted out;
    • the product name;
    • the manufacturing number and the expiry or use-by date;
    • the weight, volume or count;
    • the name of every ingredient on the licence, the quantity of active ingredient, and the quantity of preservative;
    • the words “prescription drug” or “over-the-counter drug”;
    • the items required in the package insert — which may be replaced by a barcode pointing to that content.

    The phrase to look for is 전문의약품 — prescription drug. A botulinum toxin sold for cosmetic use in Korea carries it. Its absence on something being drawn into a syringe is a question worth asking out loud.

    What opening the box actually proves

    Be clear about the limits, because this is where the ritual oversells itself.

    It does prove that the packaging existed, that it was sealed until that moment, and — more usefully — that you had a chance to read what is printed on it before it was discarded. A product already drawn up in a syringe gives you nothing to read.

    It does not prove what is inside. It does not prove the product was stored at the right temperature between the importer and that room. It does not prove the dilution. A box tells you what the product claims to be; it cannot tell you what happened to it.

    So the value of the request is not the theatre of the seal breaking. It is that an unopened box is a document, and you only get to read it once.

    The two lookups

    Both are free, public, and run by the Ministry of Food and Drug Safety.

    For a device, the ministry’s medical device information portal at emedi.mfds.go.kr carries item licence information. The licence number and the standard code printed on the box are what you search against. If a product is being presented as an approved filler, the licence should exist and the product name should match.

    For a drug, 의약품안전나라 at nedrug.mfds.go.kr carries item licence information, and — worth knowing — a published record of administrative dispositions against companies. Both were live when we checked on 24 August 2026.

    Neither lookup requires an account. We did not verify how much of either portal is available in English; assume you may need a translation app in the waiting room.

    What the law does to a clinic that gets this wrong

    The prohibitions are not vague, and they are not administrative slaps.

    Devices. Article 26(1) of the Medical Devices Act says nobody may sell, lend, give or use a medical device that has not been licensed, certified or notified — nor store or display one for those purposes. Article 51(1)2 makes a violation punishable by up to five years’ imprisonment or a fine of up to ₩50 million, and Article 51(2) allows both to be imposed together.

    Drugs. Article 62 of the Pharmaceutical Affairs Act prohibits selling — or storing, importing or displaying for sale — a drug whose ingredients or quantities differ from what was licensed, along with drugs that are contaminated, decomposed, or packaged so as to mislead about how they are used.

    A clinic using an unlicensed device is not committing a paperwork offence. It is committing a crime with a five-year ceiling.

    What this note does not claim

    We are not claiming that counterfeit product is common in Korean clinics, or rare. We did not measure it, and we found no figure we were willing to print. We are not claiming that any particular group of patients asks for the box more often than another — that belongs to anecdote, not to this site. We did not verify how the standard code is issued or how quickly a new product appears in the portals, whether either portal is usable in English, or what a clinic is obliged to do if a patient asks. Nothing here is medical or legal advice, and no clinic is named.

    What we did was read what the two Acts require to be printed, and confirm that the two government databases exist and are open to the public.

    Common questions

    Is a clinic required to open the box in front of me?

    We found no provision requiring it. The labelling duties in Article 20 of the Medical Devices Act and Article 56 of the Pharmaceutical Affairs Act fall on manufacturers and importers, not on the treating clinic, and they govern what is printed — not when the packaging is opened. Asking is a request, not a right we could locate in the statutes.

    What is the single most useful thing printed on the box?

    For a device, the licence, certification or notification number, because it can be searched against the ministry’s public database. For a drug, the manufacturing number and expiry date together with the words 전문의약품.

    Does “single use” on a device box mean anything for me?

    Article 20(7) of the Medical Devices Act requires single-use devices to carry both “single use” and “do not reuse” on the packaging. If those words are on a box whose contents are being used across more than one patient, that is a discrepancy you can see with your own eyes.

    What happens to a clinic that uses an unlicensed device?

    Use of an unlicensed, uncertified or unnotified medical device is prohibited by Article 26(1) of the Medical Devices Act, and Article 51(1)2 sets the penalty at up to five years’ imprisonment or a fine of up to ₩50 million, which may be imposed together.

    Sources

    All provisions read in the original on the National Law Information Center (국가법령정보센터), 24 August 2026. Both ministry portals accessed the same day.

    • Medical Devices Act (의료기기법), Article 20 (용기 등의 기재사항), Article 26(1) (일반행위의 금지), Article 51 (벌칙) — https://www.law.go.kr/법령/의료기기법
    • Pharmaceutical Affairs Act (약사법), Article 56(1) (의약품 용기 등의 기재 사항), Article 62 (제조 등의 금지), Article 47-3 (의약품관리종합정보센터) — https://www.law.go.kr/법령/약사법
    • Ministry of Food and Drug Safety, medical device information portal (의료기기안심책방) — https://emedi.mfds.go.kr
    • Ministry of Food and Drug Safety, 의약품안전나라 — https://nedrug.mfds.go.kr

    The Clinic Notes — verified, source-cited information on cosmetic medicine in South Korea. We accept no payments or benefits from clinics, hospitals, doctors, or referral agencies.

  • Korea Requires a Camera in the Operating Room. Asking It to Record Is a Separate Right — and a Form.

    Note №34PATIENT RIGHTS

    VERIFIED2026-08-21
    PRIMARY SOURCES4
    CLINICS NAMED0
    SPONSORSHIPNONE

    If you are put under general anaesthesia in a Korean medical institution, the operating room is required by law to have a closed-circuit camera in it — and if you ask, in writing, before the operation, the institution must record. It may refuse only on four grounds written into the statute. We read the Medical Service Act and its Enforcement Rule in the original on 21 August 2026. The part most patients get wrong: the recording is not yours to watch.

    Korea put a camera in the operating room by statute. Article 38-2 of the Medical Service Act — inserted 24 September 2021, with the implementing rule that makes it workable inserted 22 September 2023 — does two separate things, and the difference between them is where patients lose the right they think they have.

    Installing the camera and turning it on are different obligations

    Installation is unconditional. Paragraph 1: the founder of a medical institution that performs surgery on a patient who is unconscious, such as under general anaesthesia, shall install a closed-circuit television inside the operating room. No request needed, no exception written in. The text says medical institution, not hospital — so a clinic performing such surgery is inside the obligation.

    Recording is on request. Paragraph 2: where the patient or the patient’s guardian requests it, the head of the institution or the medical practitioner shall record the surgery using that camera. And the same sentence closes the escape route: they may not refuse without one of four justifiable grounds —

    • emergency surgery where delay would endanger the patient’s life or cause serious harm to body or mind;
    • high-risk surgery requiring aggressive measures to save the patient’s life;
    • where recording would significantly impair the training purpose of resident physicians at a designated training hospital;
    • other grounds equivalent to those above, as prescribed by Ministry of Health and Welfare ordinance.

    Nothing about the clinic’s preference, its insurer, or its internal policy is on that list.

    Sound is off by default. Paragraph 3: the audio recording function may not be used — unless every data subject, meaning the patient and every medical practitioner taking part, consents.

    How the request is actually made

    The Enforcement Rule, Article 39-11, turns the right into a procedure — and the procedure is where a foreign patient can lose it by default.

    • It is a form, not a conversation. The patient or guardian must complete the prescribed surgery-recording request form (Form 20-2 of the Rule) and submit it to the institution, presenting the requester’s ID or a copy, the patient’s own consent form, and — if the requester is the guardian — a document proving that relationship.
    • A guardian cannot override a conscious patient. Where the patient is conscious and has decision-making capacity, a guardian may not request recording against the patient’s wishes.
    • The hospital has to tell you the right exists. The institution must make patients aware in advance that such recording is possible — by posting a notice inside the institution, for instance — and must provide the request form to anyone asking.
    • A refusal has to be explained before the surgery. If the institution refuses on one of the four statutory grounds, it must explain the specific ground to the requester before the operation, not afterwards.
    • The refusal is logged. The institution must keep a request-handling register recording the requester, the content of the request, whether recording took place, and the specific ground for any refusal — and keep it for three years.

    The recording is not yours to watch

    This is the part that surprises people, and it is worth being blunt about. Paragraph 5 forbids the institution from letting anyone view the footage or providing a copy — including viewing it itself — except in three situations:

    • a relevant authority requests it for a criminal investigation, prosecution, or court proceedings;
    • the Korea Medical Dispute Mediation and Arbitration Agency requests it, after mediation or arbitration has begun, with the consent of the patient or the patient’s guardian;
    • every data subject — the patient and each medical practitioner who took part — consents.

    So the camera is not a viewing service. It is an evidence rule. Its practical value shows up only if something goes wrong and you enter a formal process — which, for a foreign patient, most realistically means the free mediation route we wrote about earlier, whose agency is named in the statute above.

    Two more numbers matter. Paragraph 9: the footage must be kept for at least 30 days. Paragraph 8: the institution may charge the requester the cost of viewing or providing it, within a range set by the Ministry. Thirty days is not long if you have flown home and are still deciding whether to complain.

    What happens to an institution that breaks these rules

    Leaking, altering, damaging, or improperly disclosing the footage, or using it for a purpose outside the Act, is a criminal offence: up to five years’ imprisonment or a fine of up to ₩50 million (Article 87-2(2), items 3-2 to 3-4).

    Failure to comply with Article 38-2 itself is handled differently — it is listed in Article 63(1), which lets the Minister or the local authority order the institution to correct the violation or restrict use of the facility. We did not find Article 38-2 among the administrative fines listed in Article 92.

    What this note does not claim

    We read the statute and the rule; we did not audit any institution. Specifically, we did not establish: whether sedation short of general anaesthesia counts as the unconscious state the Article describes — the text says “such as under general anaesthesia” and leaves the boundary to interpretation; how many institutions have actually installed cameras, or what enforcement has looked like; the exact commencement date in the supplementary provisions; the amount the Ministry allows to be charged for viewing; and whether the request form is available in any language other than Korean. Nothing here is legal advice.

    We are also not saying Korean operating rooms are unsafe, and this note takes no position on why the provision was enacted. It describes a right that exists in the text and how the text says to use it.

    Common questions

    Does every Korean clinic have to have a camera in the operating room?

    Article 38-2(1) applies to a medical institution that performs surgery on patients who are unconscious, such as under general anaesthesia. Installation there is mandatory and does not depend on any request. An institution that does not perform such surgery is not covered by that paragraph.

    Can the clinic refuse to record?

    Only on one of four grounds in Article 38-2(2): emergency surgery, high-risk life-saving surgery, significant impairment of resident training at a designated training hospital, or an equivalent ground prescribed by ministerial ordinance. The Enforcement Rule requires the specific ground to be explained before the surgery and entered in a register kept for three years.

    Can I watch the video of my own surgery?

    Not on request alone. Article 38-2(5) permits viewing or release only for a criminal investigation or court proceedings, for the Korea Medical Dispute Mediation and Arbitration Agency after a mediation or arbitration has started with the patient’s consent, or where every data subject consents — which includes the medical practitioners who took part.

    How long is the footage kept?

    At least 30 days under Article 38-2(9). Grounds for extending that period are left to ministerial ordinance.

    Sources

    All provisions read in the original on the National Law Information Center (국가법령정보센터), 21 August 2026.

    • Medical Service Act (의료법), Article 38-2 (수술실 내 폐쇄회로 텔레비전의 설치ㆍ운영), Article 63(1), Article 87-2(2), Article 92 — https://www.law.go.kr/법령/의료법
    • Enforcement Rule of the Medical Service Act (의료법 시행규칙), Article 39-11 (촬영의 요청 절차 등), inserted 22 September 2023, amended 18 July 2024 — https://www.law.go.kr/법령/의료법시행규칙

    The Clinic Notes — verified, source-cited information on cosmetic medicine in South Korea. We accept no payments or benefits from clinics, hospitals, doctors, or referral agencies.

  • Korea Exempts Medical Care From VAT. Then It Names the Procedures That Lose the Exemption.

    Note №33TAX

    VERIFIED2026-08-21
    PRIMARY SOURCES3
    CLINICS NAMED0
    SPONSORSHIPNONE

    Medical treatment in Korea is exempt from value-added tax. Cosmetic treatment is not — and the exemption is not removed by a general principle but by a list. We read that list in the original on 21 August 2026: the Enforcement Decree of the Value-Added Tax Act names the procedures one by one, from rhinoplasty to pore reduction. If your treatment is on it, the price you were quoted is a pre-tax price unless the clinic said otherwise.

    Ask a Seoul clinic what a treatment costs and you may get a number followed by three syllables: 부가세 별도. VAT not included. It is not a surcharge the clinic invented. It is the tax code doing something unusual — naming procedures one by one.

    The rule, the exception, and the exception to the exception

    Article 26(1)5 of the Value-Added Tax Act exempts “medical and health services (including veterinary services) as prescribed by Presidential Decree, and blood.” That is the rule: a doctor’s services are not taxed.

    The Presidential Decree that prescribes them is the Enforcement Decree, Article 35. Its first subparagraph covers services provided by doctors, dentists, oriental medicine doctors, midwives and nurses — and then removes, by proviso, the treatment excluded from health insurance benefit coverage under Article 41(4) of the National Health Insurance Act, listed in two items.

    Item (a) — surgical. Double-eyelid surgery, rhinoplasty, breast augmentation or reduction, liposuction, wrinkle removal, facial contouring, dental cosmetic work (defined in the text as tooth whitening, laminates and gum contouring) and other cosmetic surgery; plus orthognathic surgery.

    Item (b) — non-surgical. Treatment of pigmented naevi, freckles, lentigines and melasma; acne treatment; hair removal; hair-loss treatment; hair transplantation; tattooing and tattoo removal; piercing; fat dissolving; skin regeneration; skin whitening; anti-ageing treatment; and pore reduction.

    Then the decree writes some of it back. Still exempt, by the text’s own parentheses: treatment of after-effects caused by cosmetic surgery; reconstructive surgery for a congenital deformity; reconstructive surgery following tumour removal; breast reconstruction after breast cancer surgery; and orthognathic surgery preceded by orthodontic treatment.

    The rate on whatever stays taxable is flat. Article 30 of the Act: “The value-added tax rate shall be 10 percent.”

    Why a list, and not a principle

    The structure matters more than it looks. Korea did not write “cosmetic procedures are taxable” and leave the rest to interpretation. It wrote names. That has two consequences a patient can use.

    The first is that the list is amendable, and has been amended. The decree’s own heading carries its revision history — the article has been changed in 2014, 2016, 2018, 2019, 2020, 2022, 2023, 2024 and 2025, with the version we read in force from 27 February 2026 (Presidential Decree No. 36133). A treatment that was not taxed at one time may be taxed now because a line was added, not because a philosophy changed.

    The second is that a procedure’s name on a Korean price board is not the same thing as its name in the decree. Korean clinics sell treatments under device brands and nicknames, and the tax text speaks in clinical categories. Where a marketing name and a statutory category do not obviously line up, that is a question for the clinic’s front desk, not something to infer from a price list. We have written before about how device names change at the border and about what a Korean lifting price is actually quoting.

    What this changes about a quote

    Three practical things follow.

    A quoted price may be pre-tax. 부가세 별도 means 10 percent will be added. A price list that says nothing has not told you it is included. If the quote does not state which, it is a question, not an assumption.

    Reconstructive framing is not a discount you can request. The exceptions in the decree describe clinical situations — after-effects, congenital deformity, post-tumour reconstruction — not billing preferences. Whether a given treatment falls inside one of them is a medical and administrative determination made by the provider, and we did not examine how providers make it.

    The old foreign-patient refund is gone. Until the end of 2025, a foreign patient could reclaim the VAT on certain cosmetic procedures. That special refund ended on 31 December 2025, and the bill written to restore it has not passed. The 10 percent in your quote is now a 10 percent you pay.

    What this note does not claim

    We read three statutes and one decree article. We did not audit any clinic’s invoicing, and we are not saying that a clinic charging or not charging VAT on a particular treatment is doing so incorrectly. We did not verify how the tax authority classifies borderline treatments, and we did not examine the enforcement record. Nothing here is tax advice; it is the text of the rule and where to find it.

    Common questions

    Is all medical treatment in Korea taxed?

    No. The default is exemption. Value-Added Tax Act Article 26(1)5 exempts medical and health services, and only the treatment named in Article 35, subparagraph 1, items (a) and (b) of the Enforcement Decree loses that exemption.

    What rate applies to cosmetic treatment?

    Ten percent. Article 30 of the Value-Added Tax Act sets a single rate: “The value-added tax rate shall be 10 percent.”

    Does 부가세 별도 mean I will pay more than the price shown?

    Yes. It means VAT is not included in the figure. Where a price page says nothing either way, ask — silence is not a statement that tax is included.

    Can a foreign patient reclaim the VAT at the airport?

    Not since 1 January 2026. The special refund for foreign patients ended on 31 December 2025 and had not been restored as of this writing.

    Sources

    All provisions read in the original on the National Law Information Center (국가법령정보센터), 21 August 2026.

    • Value-Added Tax Act (부가가치세법), Article 26(1)5 and Article 30 — in force 2 January 2026, Act No. 21065 — https://www.law.go.kr/법령/부가가치세법
    • Enforcement Decree of the Value-Added Tax Act (부가가치세법 시행령), Article 35, subparagraph 1, items (a) and (b) — in force 27 February 2026, Presidential Decree No. 36133 — https://www.law.go.kr/법령/부가가치세법시행령
    • National Health Insurance Act (국민건강보험법), Article 41(4) — https://www.law.go.kr/법령/국민건강보험법

    The Clinic Notes — verified, source-cited information on cosmetic medicine in South Korea. We accept no payments or benefits from clinics, hospitals, doctors, or referral agencies.

  • A Korean Lifting Price Is Quoted by the Shot. What One Shot Buys Depends on the Machine.

    Note №32PRICE INTELLIGENCE

    VERIFIED2026-08-19
    PRIMARY SOURCES5
    CLINICS NAMED0
    SPONSORSHIPNONE

    Korean clinics price energy-device treatments in shots, lines, cc, Units and cartridges — not in treatments. We read the manufacturers’ own manuals on 19 August 2026. A Thermage treatment tip is specified for single-patient use. An Ultherapy transducer is specified to be wiped and used between patients. Neither manual tells you how many shots a consumable holds.

    You ask what a lifting treatment costs in Seoul. English guides answer with a range: one to two million won. Then the actual quote arrives, and it does not look like that at all. It says 300 shots. Or 600. Or 900. Sometimes it says 100 shots and a price that seems impossibly low.

    That number is not a discount tier and it is not a package size. It is a quantity of consumable — a metered part that the machine burns through and that the clinic has to buy again. Once you know that, the range in the guides stops being a price and becomes what it always was: a number with the unit removed.

    Why is a Korean price quoted in shots rather than treatments?

    Because these machines meter themselves, and the manufacturers built the counting into the device.

    The Ulthera System — sold in Korea as 울쎄라 — displays, on its own screen during treatment, the “Number of treatment lines remaining/total treatment line capacity of transducer.” When that counter hits zero the system raises an error and the manual instructs: “The Transducer’s remaining line count is zero. Remove and replace the Transducer.”

    So the quantity is real, it is enforced by the hardware, and the clinic is passing it to you. The unit is not marketing. It is the machine.

    Note the vocabulary problem already: the manufacturer’s own word is lines, and the Korean price board says 샷 (shots). Those are the same quantity under two names, and neither appears in the English guides that quote you a range.

    What is the consumable, and may it be used on more than one person?

    Here the two best-known machines part company completely, and they do it in their own documentation.

    Thermage (써마지). The Thermage CPT System technical user’s manual — model TG-2B, document P009240-06, September 2021 — says this in three separate places:

    “The Non-Sterile Treatment Tips are designed for single patient use only.” (§6.7)

    “The Treatment Tip is for single-patient-use only. Do not reuse Treatment Tips.” (§10.1.4)

    “Treatment Tips are for single patient use only. Do not reuse. Multiple patient use creates a risk of cross contamination of microorganisms from one patient to another.” (§4.2.53)

    Ultherapy (울쎄라). The Ulthera System Instructions for Use — document 1015107IFU Rev 05, April 2024 — says this:

    “Because the transducer will come in contact with the skin of a patient, the standard practice for cleaning and low-level disinfection of transducers between patients is to gently but thoroughly wipe the transducers with a standard 70% isopropyl alcohol prep pad for a minimum of one minute.” (§9.1)

    Two manufacturers, two consumables, two opposite instructions. One says the part goes in the bin after you. The other describes the procedure for cleaning it before the next person.

    This is a difference in device design, not a ranking of clinics. It is also the reason a request that sounds reasonable for one machine is meaningless for the other: you can ask to watch a Thermage tip come out of its packaging. There is no equivalent moment for an Ultherapy transducer, because the manufacturer never intended there to be one.

    ⚠️ One precision we owe you: the Thermage manual we read covers the CPT system, model TG-2B. We did not obtain the manual for the newer FLX system, and we are not asserting that its wording is identical.

    Is the Ultherapy instruction a hygiene problem?

    No — and it is important not to read it that way.

    Reusable-between-patients is an ordinary, regulated category of medical device. Ultrasound probes in hospitals work the same way, and the manufacturer does not leave the question open: the Ulthera IFU specifies the disinfectant, the technique, and the minimum contact time, and adds that “Neither the transducers nor the handpiece should be submerged in liquid” and to “Place the transducer back into its original packaging between uses.”

    We are not evaluating whether any clinic follows that procedure, and we have not reviewed any infection data. What the two manuals give you is narrower and more useful: the right question changes depending on the machine. For Thermage, the question is whether the tip is new and genuine. For Ultherapy, the question is the disinfection routine, because that is the control the manufacturer actually specifies.

    How many shots does one cartridge hold?

    We could not find out, and that is worth saying plainly.

    The Ulthera documentation confirms a transducer has a “total treatment line capacity” and shows it on screen — but none of the Merz documents we read state what that number is for any transducer model. We also could not find published cartridge shot ratings for the Korean HIFU and RF devices in their manufacturers’ own product pages.

    Numbers do circulate online. We found a specific figure being repeated on social media for the Ultherapy transducer; we could not trace it to any manufacturer or regulator document, so we are not repeating it here. An unsourced capacity figure is worse than none, because it invites arithmetic that may be entirely wrong.

    What you can rely on is the structure, not the number: the consumable is metered, the meter is visible on the machine, and the clinic knows the figure even when the internet does not.

    What else changes the number on your quote?

    Shots are only one of five axes. Change any one and two quotes stop being comparable.

    On the quote What it counts Can you verify it?
    샷 / shots Pulses drawn from a metered consumable The machine counts it; the rating is not published
    lines The manufacturer’s own word for the same quantity Shown on the Ultherapy screen during treatment
    cc / mL Volume of injected product Yes — it is on the syringe
    유닛 / Units Biological potency of a toxin Yes, but only within one brand — see below
    부위 / area Nothing quantitative at all No
    kJ Total energy delivered The machine counts it
    가닥 / ea Number of threads placed Yes

    Toxin Units are the trap. BOTOX Cosmetic’s US prescribing information states that “The potency Units of BOTOX Cosmetic are specific to the preparation and assay method utilized” (§5.1), and that units “cannot be compared to nor converted into units of any other botulinum toxin products assessed with any other specific assay method” (§2.1). For reference, that label puts a full glabellar-line dose at 20 Units, and the vials at 50 and 100 Units.

    So “50 units” quoted for one brand and “50 units” quoted for another are not the same quantity of anything. A price per unit compared across brands is not a comparison. Korean quotes make this harder still by sometimes pricing toxin in cc — which is reconstitution volume, not potency, and tells you nothing at all.

    Filler is quoted in cc or mL, which is honest, but lidocaine-containing versions of the same filler are separate products with their own approvals — so “the same filler” may not be.

    And then there is VAT. Medical services in Korea are exempt from value-added tax as a rule, but cosmetic-purpose treatment is written out of that exemption by name. The Enforcement Decree of the Value-Added Tax Act, Article 35, subparagraph 1, removes the exemption for treatment excluded from national health insurance benefit under Article 41(4) of the National Health Insurance Act, and then lists it: item (a) covers double-eyelid surgery, rhinoplasty, breast augmentation or reduction, liposuction, wrinkle removal, facial contouring, dental cosmetic work and orthognathic surgery; item (b) covers pigmented-lesion, freckle and melasma treatment, acne treatment, hair removal, hair-loss treatment, hair transplant, tattooing and tattoo removal, piercing, fat dissolving, skin regeneration, skin whitening, anti-aging treatment and pore reduction. The rate is 10 percent (Value-Added Tax Act, Article 30: “The value-added tax rate shall be 10 percent”) — we set out the full list of procedures the decree names separately. The decree writes its own exceptions back into the exemption — treatment of complications caused by cosmetic surgery, reconstruction of a congenital deformity, breast reconstruction after cancer surgery, and reconstruction after tumour removal. That is why Korean clinic price pages routinely carry the line 부가세 별도 (VAT not included). Some price lists say it. Some do not say anything, which is not the same as saying it is included. If the quote does not state which, it is a question, not an assumption — and the 10% refund that foreign patients used to reclaim at the airport ended on 31 December 2025.

    What can you ask?

    The point of all of this is not to negotiate harder. It is to make two quotes describe the same thing before you compare them.

    • “How many shots, and of what?” A price without a shot count is not a price. A shot count without the device model is not a quantity.
    • “Is the consumable single-use on this machine?” For a tip-based device you can ask to see it opened. For a transducer-based device, ask instead how it is disinfected between patients — that is the control the manufacturer specifies.
    • “Which brand, and how many Units?” For toxin, both halves are required. One without the other is not information.
    • “Is VAT included?” Ask even when the list says nothing, because saying nothing is common.
    • “Can I have the quote written down with the units on it?” A clinic that quotes in units can write in units.

    The posted-price rule that protects Korean patients has a gap that foreign patients fall through, and the first number you are given functions as an opening position rather than a fixed price. Neither of those is a reason to distrust a clinic. They are reasons to make the unit explicit before the number matters.

    If you want to check the other claim on the tablet — the FDA one — we read what four Korean radiofrequency devices were actually cleared for.

    Common questions

    Why does a Korean clinic quote lifting treatments in shots?

    Because the machines meter themselves. The Ulthera System displays the treatment lines remaining against the transducer’s total capacity and stops when it reaches zero. The clinic is passing on a quantity the hardware enforces.

    Is a Thermage tip reused between patients?

    The manufacturer says it must not be. The Thermage CPT technical manual states in three places that treatment tips are for single patient use only and warns of cross contamination between patients. We read the CPT manual, not the FLX one.

    Is an Ultherapy transducer reused between patients?

    Yes, by design. The Ulthera System IFU describes the standard practice for cleaning and low-level disinfection of transducers between patients using a 70% isopropyl alcohol wipe for at least one minute. This is an ordinary category of reusable medical device, not a defect.

    How many shots are in one cartridge?

    We do not know. The manufacturer documents we read confirm a transducer has a total line capacity and show it on screen, but none of them state the figure. Numbers circulating online could not be traced to a manufacturer or regulator, so we have not repeated them.

    Are 50 units of one toxin brand the same as 50 units of another?

    No. BOTOX Cosmetic’s prescribing information states that its potency Units are specific to its own preparation and assay method and cannot be converted into the units of any other botulinum toxin product. A price per unit compared across brands is not a comparison.

    Sources

    Manufacturer documents read in the original on 19 August 2026. Korean statutes read in the original on the National Law Information Center on 21 August 2026.

    • Thermage CPT System Technical User’s Manual, model TG-2B, document P009240-06 (September 2021), §§4.2.53, 6.7, 10.1.4 — https://ca.thermage.com/siteassets/hcp/pdf/thermage-cpt-technical-users-manual-model-tg-2b-p-np009240-06-2021.pdf
    • Ulthera System Instructions for Use, document 1015107IFU Rev 05 (April 2024), §§7.2.1, 8, 9.1 — https://merzaesthetics.com/app/uploads/2024/09/1015107IFU-Rev-05-US-Ultherapy.pdf
    • Value-Added Tax Act (부가가치세법), Article 26(1)5 and Article 30 — current text as of enforcement 2 January 2026, Act No. 21065 — https://www.law.go.kr/법령/부가가치세법
    • Enforcement Decree of the Value-Added Tax Act (부가가치세법 시행령), Article 35, subparagraph 1, items (a) and (b) — current text as of enforcement 27 February 2026, Presidential Decree No. 36133 — https://www.law.go.kr/법령/부가가치세법시행령
    • BOTOX Cosmetic US Prescribing Information, §§2.1, 2.2, 3, 5.1, via the openFDA drug label API — https://api.fda.gov/drug/label.json

    The Clinic Notes — verified, source-cited information on cosmetic medicine in South Korea. We accept no payments or benefits from clinics, hospitals, doctors, or referral agencies.

  • Korea’s Radiofrequency Lifting Devices Are FDA-Cleared. What They Were Cleared For Is Stopping Bleeding.

    Note №31REGULATORY RECORD

    VERIFIED2026-08-19
    PRIMARY SOURCES7
    CLINICS NAMED0
    SPONSORSHIPNONE

    Four Korean RF devices sold as skin tightening carry United States clearances. Read the cleared sentence and it says electrocoagulation and hemostasis — the surgical control of bleeding. Here is the exact wording of each, and what it does and does not tell you.

    You are sitting in a consultation room in Gangnam. The 상담실장 (sangdamsiljang) — the consultation manager, the one who quotes the price, and not the doctor — turns a tablet toward you. On the screen is a device you have never heard of: 볼뉴머 (Volnewmer), or 덴서티 (DENSITY), or 올리지오 (Oligio), or 텐써마 (10THERMA). Under the product photograph, in English, are two words you recognise: FDA cleared.

    Those two words are true. You can look the clearance up yourself in ten minutes, and this article will show you how. But the sentence the FDA actually cleared does not contain the words lifting, tightening, wrinkle, or skin laxity. For three of these four devices, it contains only this: electrocoagulation and hemostasis — burning tissue closed, and stopping bleeding.

    What is actually inside an FDA clearance?

    A 510(k) clearance is a finding that a new device is substantially equivalent to one already legally on the US market. It is not a finding that the device works.

    Every clearance carries one short, formal sentence called Indications for Use. That sentence — not the brochure, not the clinic’s website — is the legal description of what the device is cleared to do. It is published as a PDF on the FDA’s own server, and anyone can read it.

    This matters because “cleared” and “approved” are different things, and Korean clinic marketing in English uses them interchangeably. We have written before about what a Korean clinic menu is actually listing, and about treatments where the FDA approval count is zero.

    What were the four Korean devices cleared for?

    Here is the Indications for Use text, quoted exactly, from each clearance document.

    Device 510(k) Cleared Indications for Use — verbatim
    볼뉴머 Volnewmer (CLASSYS) K240248 29 Apr 2024 “Volnewmer™ is intended for use in dermatologic procedures for electrocoagulation and hemostasis of soft tissue.”
    덴서티 DENSITY (Jeisys Medical) K230663 14 Aug 2023 “DENSITY indicated for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis.”
    올리지오 X Oligio X (Won Tech) K240313 22 Feb 2024 “The ‘Oligio X is intended for use in dermatologic and general surgical procedures for non-invasive electrocoagulation and hemostasis of soft tissue.”
    텐써마 10THERMA (Tentech) K232992 20 Dec 2023 “10THERMA indicated for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis.”

    Four devices, four different manufacturers, four clearances issued inside nine months of each other. Not one of the four sentences mentions a wrinkle.

    Why does Thermage have wrinkle indications when these do not?

    Because Thermage was cleared for them separately, and the devices that cite it did not ask for the same list.

    써마지 (Thermage) FLX, made by Solta Medical, was cleared in 2017. Its Indications for Use is long, and it says this explicitly:

    “Non-invasive treatment of periorbital wrinkles and rhytids including upper and lower eyelids; Non-invasive treatment of wrinkles and rhytids.”

    The mode that applies RF and vibration at the same time adds “Temporary improvement in the appearance of cellulite,” relief of minor muscle aches, relief of muscle spasms, and temporary improvement of local circulation.

    Three of the four Korean devices name Thermage FLX (K170758) directly as their predicate device: Volnewmer, DENSITY, and 10THERMA. The fourth, Oligio X, names an earlier Won Tech model, The Oligio (K221989, cleared 13 Oct 2022) — and that clearance names Thermage FLX. So the lineage reaches Thermage in every case; for Oligio X it takes one extra step.

    A predicate is an ancestor, not an inheritance. Citing a device does not transfer that device’s indication list to yours. We could not find an FDA statement explaining why these four sought the narrower wording, and we are not going to guess at the reason.

    Is InMode different?

    Yes — and not in the way you would expect. 인모드 (InMode) is not one device. It is a console with interchangeable handpieces, and each handpiece was cleared for something different under a single 2022 clearance.

    Handpiece Indications for Use — verbatim
    Forma (Plus, Plus90, Plus-Plus) “indicated for the temporary relief of minor muscle aches and pain, temporary relief of muscle spasm, and temporary improvement of local blood circulation.”
    Morpheus8 “intended for use in dermatological procedures for electrocoagulation and hemostasis.”
    Fractora 3D “intended for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis.”
    FaceFX (WMFace) “intended for use in dermatologic procedures, for noninvasive treatment of mild to moderate facial wrinkles and rhytids.”
    BodyFX “…Relief of minor muscle aches and pains, relief of muscle spasm, temporary improvement of local blood circulation. Temporary reduction in the appearance of cellulite.”

    Forma is one of the handpieces sold in Korea as a lifting treatment. In its US clearance it is a muscle-ache and blood-circulation device. Morpheus8, the most internationally famous name on this list, is cleared for electrocoagulation and hemostasis. FaceFX is the only handpiece in the table whose cleared sentence contains the word “wrinkles.”

    If a clinic tells you the machine is FDA-cleared, that statement can be true while the specific handpiece being used on your face is cleared for something else entirely.

    Does this mean the devices do not work?

    No. This article does not say that, and cannot.

    Three things are true at once, and they need to be kept apart:

    1. In the United States, using a device outside its cleared indications is lawful. A licensed physician there may use a cleared device for a purpose the clearance does not list; this is ordinary medical practice, not a violation. We did not verify how Korea treats off-label device use, and we make no claim about it here.
    2. A clearance is not an efficacy verdict. A 510(k) says a device is substantially equivalent to an earlier one. The absence of a wrinkle indication is not evidence that a device fails to tighten skin. It is evidence about a regulatory filing, and nothing more.
    3. We did not check Korean approvals. These devices are used in Korea under Korean regulation, and 식약처 (MFDS) — Korea’s drug and device authority — makes its own determinations. We did not look up what any of these devices are approved for in Korea, and nothing here should be read as a claim about their Korean status.

    What this article says is narrower, and we think more useful: the two English words on the tablet do not mean what a foreign patient reasonably assumes they mean, and the document that says what they do mean is free, public, and four clicks away.

    What can you ask before the treatment?

    Ask for the exact model name in English, not the Korean product name. The two often differ, and a device sold under one name in Korea may be exported under another — we have written about what happens to device names at the border.

    Then, if the clinic has told you the device is FDA-cleared:

    • Ask for the K-number. Every clearance has one, in the format K + six digits. A clinic making the claim should be able to produce it.
    • Read the sentence yourself. Search the K-number at accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm, then open the linked PDF and find “Indications for Use.” It is one paragraph.
    • For InMode, ask which handpiece. The console clearance and the handpiece clearance are not the same question.
    • Ask what the device is approved for in Korea. That is the regulation you are actually being treated under. We did not research this; the clinic can tell you, and 식약처 maintains the record.

    None of this makes a treatment better or worse. It changes what you are agreeing to — from a marketing phrase to a document you have read.

    Common questions

    Is “FDA-cleared” the same as “FDA-approved”?

    No. Clearance (510(k)) is a finding of substantial equivalence to an existing device. Approval (PMA) is a separate, much heavier review pathway. Korean clinic marketing in English frequently uses “approved” where the record says “cleared.”

    Does electrocoagulation and hemostasis mean the device is a surgical tool?

    It means the cleared use is burning tissue closed and stopping bleeding. Whether a given device is also effective for skin tightening is a separate question that the clearance document does not answer either way.

    Are these devices unsafe?

    Nothing in this article supports that conclusion. A narrow indications statement is a fact about a regulatory filing, not a safety finding. We did not review any safety data.

    Are these devices unapproved in Korea?

    We do not know. We did not check the 식약처 (MFDS) record for any of them. Do not read a US clearance’s wording as a statement about Korean approval.

    Which lifting device should I choose?

    We do not make treatment recommendations and will not start here. What this article gives you is a way to check one specific claim — the FDA one — against its source.

    Sources

    All FDA documents accessed 19 August 2026.

    • Volnewmer, K240248 (CLASSYS Inc., cleared 29 April 2024) — https://www.accessdata.fda.gov/cdrh_docs/pdf24/K240248.pdf
    • DENSITY, K230663 (Jeisys Medical Inc., cleared 14 August 2023) — https://www.accessdata.fda.gov/cdrh_docs/pdf23/K230663.pdf
    • Oligio X, K240313 (Won Tech Co., Ltd., cleared 22 February 2024) — https://www.accessdata.fda.gov/cdrh_docs/pdf24/K240313.pdf
    • The Oligio, K221989 (Won Tech Co., Ltd., cleared 13 October 2022) — https://www.accessdata.fda.gov/cdrh_docs/pdf22/K221989.pdf
    • 10THERMA, K232992 (Tentech Inc., cleared 20 December 2023) — https://www.accessdata.fda.gov/cdrh_docs/pdf23/K232992.pdf
    • Thermage FLX System, K170758 (Solta Medical Inc., cleared 22 September 2017) — https://www.accessdata.fda.gov/cdrh_docs/pdf17/K170758.pdf
    • InMode Multi System, K221571 (InMode Ltd., cleared 30 June 2022) — https://www.accessdata.fda.gov/cdrh_docs/pdf22/K221571.pdf
    • FDA, Premarket Notification 510(k) — https://www.fda.gov/medical-devices/premarket-submissions-selecting-and-preparing-correct-submission/premarket-notification-510k
    • FDA 510(k) Premarket Notification database — https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm

    The clearance sentence is one half of what a clinic tells you about a machine. The other half is the number on the quote — and a Korean lifting price is counted in shots, not treatments.

    The Clinic Notes — verified, source-cited information on cosmetic medicine in South Korea. We accept no payments or benefits from clinics, hospitals, doctors, or referral agencies.

  • Why Do Six in Ten Foreign Patients in Korea Go to Dermatology? What the Numbers Do — and Don’t — Explain.

    Note №30PATIENT STATISTICS

    VERIFIED2026-08-18
    PRIMARY SOURCES2
    CLINICS NAMED0
    SPONSORSHIPNONE

    Of the 2.01 million foreign patients Korea treated last year, 62.9% went to dermatology. Not plastic surgery — the specialty Korea is famous for — which took 11.2%. Nearly six skin patients for every surgery patient. Why?

    The honest answer is that the ministry’s statistics describe the skew precisely but do not explain it. What we can do is lay out what the numbers themselves say, and separate that from speculation.

    What the data actually shows

    • The growth is nearby. The three largest groups — China (618,973), Japan (600,009), Taiwan (185,715) — are all short-haul markets. A skin session fits a weekend trip; surgery, with recovery time, does not.
    • The venue matches the treatment. 87.7% of foreign patients were treated at clinic-level institutions, not hospitals. Non-surgical dermatology is exactly what small clinics deliver at volume.
    • The skew is accelerating. Dermatology’s share rose from 56.6% (2024) to 62.9% (2025) while plastic surgery’s share stayed flat — the two million new arrivals are overwhelmingly skin customers.
    • Repeatability drives volume. Statistically, a patient counted once for surgery may return yearly for skin work. Toning, boosters and lifting devices are maintenance products — the count structurally favours them.

    What people say that the data cannot confirm

    Commentary routinely credits K-drama and K-pop “glass skin” aesthetics, social-media before/afters, and price advantages over home-country dermatology. All plausible; none measurable in the ministry’s release, so we present them as the popular explanation, not the established one. What the release does show is money: foreign patients’ reported medical spending reached ₩3.3 trillion in 2025.

    If you are one of the 62.9%

    • You are in the most competitive segment of Korean medicine — which is good for prices and availability, and exactly why quotes move and marketing is aggressive.
    • It is also the fastest-growing complaint category. Korea’s dispute agency logged a 96.6% rise in dermatology complaints in its latest yearbook. Popularity and problems scale together; know the dispute channel.
    • The full statistics are in our companion article — Korea’s two-million-patient year, in numbers.

    Sources and last verification

    • Ministry of Health and Welfare, 2025 foreign patient statistics (announced 24 April 2026) — mt.co.kr — accessed 18 August 2026
    • Ministry of Health and Welfare, 2024 statistics (announced 2 April 2025) — medigatenews.com — accessed 18 August 2026

    Verified 18 August 2026. The “why” sections distinguish measured facts from popular explanation by design.

  • The Device Name on Your Korean Treatment Menu May Not Exist Outside Korea.

    Note №29REGULATORY RECORD

    VERIFIED2026-08-18
    PRIMARY SOURCES2
    CLINICS NAMED0
    SPONSORSHIPNONE

    You had HIFU lifting in Seoul. Back home, you tell your dermatologist you had “Shurink.” They have never heard of it — and neither has any regulator in their country. That is not because the machine is obscure. It is because in Korean clinics, several of the most common device and product names change — or quietly stop existing — the moment you cross a border.

    We have verified each example below against primary regulatory records for earlier articles on this site; this piece collects them in one place, because the pattern itself is the useful knowledge.

    Same machine, different passport

    Name on the Korean menuWhat it is elsewhere
    슈링크 (Shurink)Sold abroad as Ultraformer. No FDA clearance exists under either name; the manufacturer’s US-cleared devices are different models entirely
    울쎄라 (Ulthera)Real US device — but authorised via a De Novo pathway (2009) and later 510(k)s, which is not the same thing as “FDA approved”
    써마지 (Thermage)US 510(k)-cleared — with cleared indications that do not include the lifting language Korean marketing uses
    리쥬란 (Rejuran)Long called “Asia-only” — no longer true: it obtained EU CE marking under the MDR in December 2024. It remains unavailable in the US
    스컬트라 (Sculptra)The rare one with a full FDA premarket approval (PMA)

    Why this matters more than trivia

    • Your aftercare depends on it. A doctor at home cannot look up “Shurink.” Ask your Korean clinic to write down the device’s export name and the treatment parameters — and keep it with your treatment records.
    • “FDA approved” usually is not. Most aesthetic devices reach the US market through clearance pathways (510(k), De Novo) that involve far less evidence than approval. When a clinic’s English page says “FDA approved,” the accurate word is usually “cleared” — and sometimes neither applies to the Korean-market model at all.
    • Names are marketing territory. Korean treatment menus already run on nickname conventions; device branding by market is one more layer. None of this means the treatment is bad — it means the name alone is not information.

    What this article does not claim

    Nothing here says these devices are unsafe or ineffective, and no clinic is named. Regulatory status describes what a regulator has reviewed — not how good the treatment is. Statuses also change; the entries above reflect records as verified for our earlier coverage and re-checked on the date below.

    Sources and last verification

    • FDA device databases (De Novo DEN080006 for Ultherapy; 510(k) K170758 for Thermage FLX; PMA P030050/S039 for Sculptra) — verified for earlier articles on this site — re-checked 18 August 2026
    • EU CE MDR certification of Rejuran (26 December 2024) — manufacturer announcement, previously verified — accessed 18 August 2026
    • Classys (Shurink/Ultraformer manufacturer) US clearance records — previously verified: no clearance under the Shurink or Ultraformer names — accessed 18 August 2026

    A name is only the first layer. The regulatory sentence attached to a device can be narrower still: we read the clearance text for four Korean radiofrequency devices and not one of them mentions a wrinkle.

    Verified 18 August 2026. Regulatory statuses change; check the FDA and EU databases for the current record.

    Related. One layer below the name is the packaging. Korean law fixes what must be printed on a device box and on a drug vial — and two of those items can be checked against a public database before treatment: what to read on the box, and what opening it does not prove.

  • Korea Treated 2 Million Foreign Patients Last Year. Six in Ten Went to a Dermatologist.

    Note №28PATIENT STATISTICS

    VERIFIED2026-08-18
    PRIMARY SOURCES3
    CLINICS NAMED0
    SPONSORSHIPNONE

    If you are reading this site because you are considering a skin treatment in Korea, here is the single most contextualising number we can offer: last year, 2.01 million foreign patients were treated in Korea — the first time the figure has ever passed two million — and 62.9% of them, about 1.31 million people, went to a dermatology clinic.

    The figures come from the Ministry of Health and Welfare’s annual count, announced in April 2026. They describe a market that has not just recovered since the pandemic but changed shape: growth is being driven almost entirely by skin, not surgery.

    The numbers

    Foreign patients in Korea20242025
    Total1.17 million2.01 million (+72%)
    Dermatology share56.6%62.9% (1.31m)
    Plastic surgery share11.4%11.2% (233k)
    Treated at clinic-level institutions (의원)82.0%87.7%
    Treated in Seoul85.4%87.2%

    By nationality, China led 2025 with 618,973 patients (up 137.5%), Japan followed with 600,009, and Taiwan — the fastest-growing sizeable group two years running — sent 185,715, up 122.5%. Reported medical spending reached ₩3.3 trillion. For scale: in the whole period 2009–2024, Korea’s cumulative count was about 5 million foreign patients; 2025 alone added another two.

    What the shape of the data tells you

    • You are not an edge case. Whatever nervousness you feel booking treatment abroad, the system you are entering processed two million people like you last year. Intake forms, payment flows and aftercare instructions for foreigners are now routine at the clinics doing this volume.
    • The typical foreign patient is not getting surgery. Dermatology outnumbers plastic surgery nearly six to one. The representative visit is a non-surgical skin treatment at a small Seoul clinic — exactly the segment where pricing, package terms and review reliability matter most.
    • Volume cuts both ways. Korea’s medical-dispute agency reported dermatology as its fastest-growing complaint category in its latest yearbook (+96.6%). More patients means more of everything — including things going wrong. Know the dispute system before you need it.

    Why is the skew toward dermatology so extreme? That question deserves its own article — we look at what the numbers do and do not explain in a companion piece.

    Sources and last verification

    • Ministry of Health and Welfare, 2025 foreign patient statistics (announced 24 April 2026), as reported with full figures by Money Today — mt.co.kr — accessed 18 August 2026
    • Ministry of Health and Welfare, 2024 foreign patient statistics (announced 2 April 2025) — medigatenews.com — accessed 18 August 2026
    • Korea Medical Dispute Mediation and Arbitration Agency, 2025 statistical yearbook (dermatology complaint growth) — previously verified for our dispute-system coverage — accessed 18 August 2026

    Verified 18 August 2026. Annual statistics are revised occasionally; the ministry’s releases are the primary source.

    Related: those 2.01 million patients are served by a registered supply side — paid patient referral is a criminal offence in Korea, and foreign patients are the only carve-out.

  • Olive Young’s Foreign Sales Went From 2% to 25% in Three Years.

    Note №27RETAIL DATA

    VERIFIED2026-08-18
    PRIMARY SOURCES2
    CLINICS NAMED0
    SPONSORSHIPNONE

    If you have stood in an Olive Young in Myeong-dong recently and wondered why half the store seems to be visitors with suitcases, the company’s own numbers say you were not imagining it. In 2022, foreign customers were 2% of Olive Young’s offline sales. In 2025, they were 25% — and spent over ₩1 trillion in eleven months.

    The figures come from CJ Olive Young’s December 2025 announcement, and they describe something bigger than one retailer’s good year: Korea’s beauty chain has effectively become tourism infrastructure.

    The numbers, in one table

    Foreign customers at Olive YoungFigure
    Share of offline sales, 20222%
    Share of offline sales, 202310%
    Share of offline sales, 202525%
    Foreign sales, Jan–Nov 2025over ₩1 trillion
    Share of Korea’s domestic cosmetics tax-free transactions88%
    Countries whose visitors processed tax refunds190
    “Global tourist zone” stores, Nov 2025135

    It is not just Seoul anymore

    Comparing January–October 2025 with 2022, Olive Young’s foreign sales outside the capital region grew 87-fold — Jeju nearly 200-fold, Gwangju 72-fold, Busan 59-fold. About 40% of foreign customers visited two or more stores on a trip. The K-beauty shopping run has become a repeatable itinerary item, not a Myeong-dong one-off.

    Three practical notes before you shop

    • The tax refund happens at the till. Immediate refund on qualifying purchases is why 88% of the country’s domestic cosmetics tax-free transactions run through this one chain — bring your passport, and note the on-the-spot caps differ from the medical VAT story we’ve covered.
    • Functional claims on the shelf are regulated claims. The 기능성화장품 label system we describe in a companion article applies to exactly the products filling these stores.
    • Retail is the safe end of K-beauty. Nothing sold on an Olive Young shelf involves the clinic-side questions — licensing, procedures, disputes — that the rest of this site exists to untangle.

    Sources and last verification

    • CJ Olive Young announcement of foreign-customer figures (3 December 2025), as reported with full numbers by Cheonji Ilbo — newscj.com — accessed 18 August 2026
    • Corroborating retail-press coverage of the ₩1 trillion foreign-sales milestone — mstoday.co.kr — accessed 18 August 2026

    Verified 18 August 2026. Company-reported figures; the underlying press statement is the primary source.